RONTALIZUMAB
UNII LDO2FIQ61I

Substance Identification & Data

This profile provides standardized clinical and technical data for Rontalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LDO2FIQ61I.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 948570-30-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LDO2FIQ61I

CAS Registry Number

948570-30-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RONTALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C95794

National Cancer Institute reference terminology for clinical and research data.

INN ID

9114

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-59

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rontalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.